ATE534038T1 - Neurodegenerative marker für alzheimer-krankheit - Google Patents

Neurodegenerative marker für alzheimer-krankheit

Info

Publication number
ATE534038T1
ATE534038T1 AT09013088T AT09013088T ATE534038T1 AT E534038 T1 ATE534038 T1 AT E534038T1 AT 09013088 T AT09013088 T AT 09013088T AT 09013088 T AT09013088 T AT 09013088T AT E534038 T1 ATE534038 T1 AT E534038T1
Authority
AT
Austria
Prior art keywords
disease
alzheimer
markers
neurodegenerative
values
Prior art date
Application number
AT09013088T
Other languages
English (en)
Inventor
Aye Mu Myint
Manfred Schawaller
Markus J Schwarz
Harald Hampel
Original Assignee
Univ Antwerp
Univ Maastricht
Klinik Und Poliklinik Fuer Psychiatrie Und Psychotherapie
Verstappen Leopold
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Antwerp, Univ Maastricht, Klinik Und Poliklinik Fuer Psychiatrie Und Psychotherapie, Verstappen Leopold filed Critical Univ Antwerp
Application granted granted Critical
Publication of ATE534038T1 publication Critical patent/ATE534038T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G01N33/9406—Neurotransmitters
    • G01N33/942—Serotonin, i.e. 5-hydroxy-tryptamine
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2814—Dementia; Cognitive disorders
    • G01N2800/2821—Alzheimer
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/145555—Hetero-N

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Eye Examination Apparatus (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Mushroom Cultivation (AREA)
  • Input From Keyboards Or The Like (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
AT09013088T 2005-04-06 2006-03-30 Neurodegenerative marker für alzheimer-krankheit ATE534038T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP05007558 2005-04-06

Publications (1)

Publication Number Publication Date
ATE534038T1 true ATE534038T1 (de) 2011-12-15

Family

ID=36293430

Family Applications (2)

Application Number Title Priority Date Filing Date
AT09013088T ATE534038T1 (de) 2005-04-06 2006-03-30 Neurodegenerative marker für alzheimer-krankheit
AT06723873T ATE468537T1 (de) 2005-04-06 2006-03-30 Neurodegenerative marker für depression.

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT06723873T ATE468537T1 (de) 2005-04-06 2006-03-30 Neurodegenerative marker für depression.

Country Status (13)

Country Link
US (2) US20080131921A1 (de)
EP (2) EP1866650B1 (de)
JP (1) JP4958893B2 (de)
AT (2) ATE534038T1 (de)
CY (1) CY1110116T1 (de)
DE (1) DE602006014379D1 (de)
DK (2) DK1866650T3 (de)
ES (2) ES2346467T3 (de)
NO (2) NO20075671L (de)
PL (2) PL2146209T3 (de)
PT (2) PT1866650E (de)
SI (1) SI1866650T1 (de)
WO (1) WO2006105907A1 (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5856364B2 (ja) * 2006-08-04 2016-02-09 味の素株式会社 抑うつ病の評価方法、抑うつ病評価装置、抑うつ病評価方法、抑うつ病評価システム、抑うつ病評価プログラム、記録媒体および端末装置
AT9843U1 (de) 2007-03-27 2008-04-15 Kepplinger Berthold Dr Messung von biologischen markern
SG10201704689XA (en) 2008-01-18 2017-07-28 Harvard College Methods of detecting signatures of disease or conditions in bodily fluids
JP5410997B2 (ja) * 2008-01-31 2014-02-05 則行 川村 うつ病およびうつ状態のマーカーおよびそれを用いた検出・診断
WO2009100243A2 (en) * 2008-02-05 2009-08-13 University Of Miami Elavl4 as a predictor of depression in alzheimer's disease and parkinson's disease patients
JPWO2011019072A1 (ja) 2009-08-12 2013-01-17 ヒューマン・メタボローム・テクノロジーズ株式会社 うつ病のバイオマーカー、うつ病のバイオマーカーの測定法、コンピュータプログラム、及び記憶媒体
CA2806304A1 (en) 2010-07-23 2012-01-26 President And Fellows Of Harvard College Methods of detecting prenatal or pregnancy-related diseases or conditions
MX2013000917A (es) 2010-07-23 2013-07-05 Harvard College Metodos para detectar las enfermedades o condiciones usando celulas fagociticas.
AU2011280997A1 (en) 2010-07-23 2013-02-28 President And Fellows Of Harvard College Methods of detecting autoimmune or immune-related diseases or conditions
SG10201505723UA (en) 2010-07-23 2015-09-29 Harvard College Methods for detecting signatures of disease or conditions in bodily fluids
DK2778233T3 (en) 2011-11-10 2017-03-20 Human Metabolome Tech Inc METHOD OF MEASURING ETHANOLAMINPHOSPHATE
EA201590024A1 (ru) 2012-06-15 2015-05-29 Гарри Стилли Способы определения заболеваний или состояний с применением циркулирующих болезненных клеток
CN104603289A (zh) 2012-06-15 2015-05-06 哈里·斯泰利 检测疾病或病状的方法
WO2014068144A1 (en) 2012-11-05 2014-05-08 Ospedale San Raffaele S.R.L. Biomarkers of multiple myeloma development and progression
WO2014164362A1 (en) 2013-03-09 2014-10-09 Harry Stylli Methods of detecting prostate cancer
NZ771629A (en) 2013-03-09 2022-12-23 Harry Stylli Methods of detecting cancer
EP2799878A1 (de) * 2013-05-03 2014-11-05 SALION GmbH In vitro Verfahren zur Früherkennung von potenziellen Entzündungen, insbesondere im Zusammenhang mit der Abstoßung eines Transplantats
US20160003857A1 (en) * 2014-07-02 2016-01-07 Cecil Bennett Methods and systems for detecting polypharmacy
EP4428251A3 (de) 2014-09-11 2024-12-18 Immunis.AI, Inc. Verfahren zum nachweis von prostatakrebs
WO2017185085A1 (en) * 2016-04-22 2017-10-26 Board Of Regents Of The University Of Nebraska Biomarkers for monitoring immune transformation
EP3413050A1 (de) * 2017-06-08 2018-12-12 SALION GmbH In vitro verfahren zur erkennung neurodegenerativer erkrankungen
US11079329B2 (en) * 2017-09-27 2021-08-03 University of North Carolina Wilmington Human waste water and human-derived pathogen scouting tool
US20210041460A1 (en) * 2018-03-19 2021-02-11 Fujifilm Wako Pure Chemical Corporation Method for judging psychiatric disorder
WO2019182003A1 (ja) * 2018-03-22 2019-09-26 株式会社日本医療機器技研 生体吸収性ステント
KR102159344B1 (ko) * 2019-08-05 2020-09-23 한국과학기술연구원 행위 중독의 진단용 조성물, 키트 및 이를 이용한 행위 중독의 진단을 위한 키누레닌의 검출 방법
WO2021106724A1 (ja) * 2019-11-26 2021-06-03 京セラ株式会社 ストレス計測システムおよびストレス計測方法
WO2022075354A1 (en) * 2020-10-06 2022-04-14 Okinawa Institute Of Science And Technology School Corporation A method for obtaining an index for the diagnosis of alzheimer's disease (ad)
WO2024253194A1 (ja) * 2023-06-08 2024-12-12 東洋紡株式会社 脳機能レベルの層別化を支援するための方法、層別化装置、及び層別化プログラム
CN118566488B (zh) * 2024-04-10 2026-02-27 合肥歆智医疗器械有限公司 抑郁症检测用试剂组合、制造方法、检测系统及其应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6194217B1 (en) * 1980-01-14 2001-02-27 Esa, Inc. Method of diagnosing or categorizing disorders from biochemical profiles
JP2000131318A (ja) * 1998-10-22 2000-05-12 Nikken Foods Co Ltd 快・不快ストレス状態解析方法
EP1050758A1 (de) * 1999-05-03 2000-11-08 Evotec BioSystems AG Methoden zur Diagnostizierung oder zur Behandlung von neuropsychiatrischen Erkrankungen, die auf erhöhten Neurotrophin 3-Spiegel basiert sind
FR2827045B1 (fr) * 2001-07-05 2007-08-10 Univ Pasteur Methodes et compositions pour la selection et le developpement de nouveaux agents pharmacologiques ou de nouveaux medicaments
JP2004198325A (ja) * 2002-12-19 2004-07-15 Oriental Yeast Co Ltd ストレスの測定方法

Also Published As

Publication number Publication date
JP4958893B2 (ja) 2012-06-20
PT1866650E (pt) 2010-06-01
SI1866650T1 (sl) 2010-12-31
NO20075671L (no) 2007-11-06
EP2146209B1 (de) 2011-11-16
EP1866650B1 (de) 2010-05-19
PL2146209T3 (pl) 2012-05-31
ES2346467T3 (es) 2010-10-15
WO2006105907A1 (en) 2006-10-12
ATE468537T1 (de) 2010-06-15
DK2146209T3 (da) 2012-02-13
PT2146209E (pt) 2011-12-30
US20120196300A1 (en) 2012-08-02
HK1137219A1 (en) 2010-07-23
DE602006014379D1 (de) 2010-07-01
NO20120452L (no) 2007-11-06
PL1866650T3 (pl) 2011-04-29
CY1110116T1 (el) 2015-01-14
EP1866650A1 (de) 2007-12-19
DK1866650T3 (da) 2010-09-06
US20080131921A1 (en) 2008-06-05
EP2146209A1 (de) 2010-01-20
JP2008537111A (ja) 2008-09-11
ES2377704T3 (es) 2012-03-30

Similar Documents

Publication Publication Date Title
ATE468537T1 (de) Neurodegenerative marker für depression.
WO2008089994A8 (en) Use of igfbp-7 in the assessment of heart failure
CY1112737T1 (el) Ισοτοπικα σεσημασμενες ενωσεις βενζοfuran σαν παραγοντες απεικονισης για πρωτεϊνες δημιουργιας αμυλοειδους (αμυloid)
DK1719116T3 (da) Skift fra ACELP- til TCX-indkodningstilstand
EP1956962A4 (de) Verfahren zur bestimmung der form eines biegbaren instruments
GB0512401D0 (en) Method
EP1872705A4 (de) Endoskopförmige nachweisvorrichtung
ATE471512T1 (de) Verwendung des proteins s100a 12 als marker für kolorektalkarzinom
AR054479A1 (es) Metodo para diagnosticar l a enfermedad de alzheimer
EP2062052A4 (de) Verfahren zur bestimmung einer analytkonzentration
WO2006090389A3 (en) Novel diagnostic markers, especially for in vivo imaging, and assays and methods of use thereof
WO2011045415A3 (en) Imaging agents and their use for the diagnostic in vivo of neurodegenerative diseases, notably alzheimer's disease and derivative diseases
FR2874675B1 (fr) Frein pour roue avec capteur d'usure
FR2816411B1 (fr) Moyens de detection de la transformation pathologique de la proteine app et leurs applications
WO2005124356A3 (en) Use of protein cbp2 as a marker for colorectal cancer
FR2890446B1 (fr) Methode de detection d'interaction intracellulaire entre bio-molecules
DE602007004570D1 (de) Verwendung von Nogo-C bei der Beurteilung von Herzversagen
DE60330218D1 (de) Mikrosensor zur Gasgehaltsmessung
ATE530548T1 (de) Neue dibenzoäc,hüä1,5ü naphthyridine und ihre verwendung als dna-sonden
DE602005011806D1 (de) Rna-biotest
DE60324820D1 (de) Verfahren zum testen des oxidiertes-ldl-beta-2-glycoprotein-i-komplexes in vivo
DK1747465T3 (da) Anvendelse af hidtil ukendte biomarkører til detektion af testikelcarcinom in situ og afledte cancere i humane prøver
WO2005116659A3 (en) Compositions and methods relating to alzheimer’s disease
FR2852096B1 (fr) Instrument indicateur de direction permettant d'indiquer l'heure et la direction de la mecque.
ATE442084T1 (de) Messung des energieverbrauchs